A. Klibanski
Journal of Clinical Endocrinology and Metabolism · 2001–2012
A researcher in the Science corpus: 6 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from A. Klibanski's perspective
Ordered by how strongly the researchers A. Klibanski trusts endorse each paper. Same corpus, a different order for every researcher.
- Activation of p53 by MEG3 Non-coding RNA* (Journal of Biological Chemistry)
- Blinded by the Light: The Growing Complexity of p53. (Cell)
- Role of angiogenesis in tumor growth and metastasis. (Seminars in Oncology)
- Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. (Journal of Clinical Endocrinology and Metabolism)
- microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer (Oncogene)
- The functional role of long non-coding RNA in human carcinomas (Molecular Cancer)
- TP53 mutations in human cancers: origins, consequences, and clinical use. (Cold Spring Harbor Perspectives in Biology)
- The p53 pathway: positive and negative feedback loops (Oncogene)
- Factors influencing mortality in acromegaly. (Journal of Clinical Endocrinology and Metabolism)
- Criteria for cure of acromegaly: a consensus statement. (Journal of Clinical Endocrinology and Metabolism)
Their papers
- MEG3 noncoding RNA: a tumor suppressor (2012) — 699 citations
- Activation of p53 by MEG3 Non-coding RNA* (2007) — 634 citations
- A consensus on criteria for cure of acromegaly. (2010) — 771 citations
- Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. (2008) — 739 citations
- Osteoporosis prevention, diagnosis, and therapy. (2001) — 4,273 citations
- Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. (2001) — 630 citations